
The updated guidelines formally incorporate Lp(a) testing into routine lipid assessment, addressing the previously noted delay in adopting this informative lab test. Recognizing Lp(a) as an independent cardiovascular risk factor should improve risk stratification and influence decisions about who needs earlier or lifelong preventive therapy. The change closes a gap between evidence and practice and underscores a broader move toward earlier, more personalized heart-disease prevention.
Click a connection line between nodes to view confidence and evidence.